VisualSonics Inc.

VisualSonics Inc.

March 20, 2007 08:00 ET

VisualSonics Receives Frost & Sullivan's Best Customer Value Award

Vevo 770® recognized for its utility, broad range of applications and its total value proposition for preclinical research and drug development

TORONTO, ONTARIO--(CCNMatthews - March 20, 2007) - VisualSonics has been awarded the Best Customer Value" Award by Frost & Sullivan for its Vevo 770® micro-ultrasound system for preclinical research.

"With the FDA's Critical Path and the NIH both heavily endorsing quantitative and translatable approaches to preclinical research and drug development, the use of in vivo imaging is expanding dramatically," says Subha B. Basu, Ph.D., senior analyst and author of Frost and Sullivan's North American Preclinical Small Animal Imaging Markets Report. "After many interviews with leading experts and customers, Frost & Sullivan has selected VisualSonics and its Vevo 770 micro-ultrasound system for the "Best Customer Value" Award due to the system's utility, the comprehensive range of applications for which it can be used, and for the total value proposition that it facilitates. In addition," says Basu, "VisualSonics has an extremely satisfied and rapidly growing customer base globally in both academic research and industry and is projected to continue to be a major modality in the small animal in vivo imaging market".

"We believe that micro-ultrasound and our Vevo 770 system is the most powerful, useful and affordable preclinical modality for in vivo soft-tissue, functional, and molecular imaging," says VisualSonics President and CEO Tom Little. "We are very pleased with the Frost & Sullivan award and even more satisfied that the award is based on industry and customer interviews and feedback, which further validates our modality and the value that it provides to leading researchers working in academia and drug development."

VisualSonics has sold over 300 of its Vevo micro-ultrasound systems worldwide in 4 years, making it one of the fastest growing modalities. With an extensive collection of peer-reviewed papers and with high-throughout, multiple-instrument Vevo installations in many pharmaceutical and biotech companies, the Vevo is becoming a standard for many applications including cardiovascular, cancer research, developmental biology and stem cell research.

About VisualSonics

VisualSonics is the world's leading developer of high-resolution, ultrasound-based, in vivo micro-imaging systems designed specifically for non-invasive preclinical research. The company's enabling micro-ultrasound technology, the Vevo 770, allow researchers at the world's most prestigious pharmaceutical and biotechnology companies, hospitals and research centers to conduct genetic research, phenotypic study and drug development.

Micro-ultrasound is one of the fastest growing preclinical imaging modalities. When compared to other imaging options, only micro-ultrasound has the combination of high-resolution, real-time imaging, in vivo detection and analysis, reasonable cost, ease-of-use, portability and no negative biological effects. More information on VisualSonics can be found at www.visualsonics.com.

About Frost & Sullivan

Frost & Sullivan, a global growth consulting company has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit www.awards.frost.com.

In the preclinical imaging industry, Frost & Sullivan has performed extensive primary and secondary research including hundreds of customer and subject matter expert interviews to compile the "North American Preclinical Small Animal Imaging Markets" Study, a key research service in addressing the growing micro-imaging marketplace.

Contact Information